0001104659-15-070710.txt : 20151113 0001104659-15-070710.hdr.sgml : 20151113 20151014180648 ACCESSION NUMBER: 0001104659-15-070710 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20151014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Strongbridge Biopharma plc CENTRAL INDEX KEY: 0001634432 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981130690 STATE OF INCORPORATION: L2 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 BUSINESS PHONE: (610) 254-9200 MAIL ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 FORMER COMPANY: FORMER CONFORMED NAME: Cortendo AB DATE OF NAME CHANGE: 20150219 CORRESP 1 filename1.htm

 

October 14, 2015

 

U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC  20549

 

Re:                             Strongbridge Biopharma plc

Registration Statement on Form F-1 (File No. 333-206654)

 

Ladies and Gentlemen:

 

As representative of the several underwriters of Strongbridge Biopharma plc’s proposed initial public offering, we hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Daylight Time, on October 15, 2015, or as soon thereafter as practicable.

 

In connection with the above-captioned Registration Statement, and pursuant to Rule 460 under the Securities Act of 1933, as amended, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to prospective underwriters, dealers and institutional investors, prior to the requested effective time of the Registration Statement.

 

We have been informed by the participating underwriters that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

[signature page follows]

 


 

Very truly yours,

 

 

 

Stifel, Nicolaus & Company, Incorporated

 

As Representative of the several Underwriters

 

 

 

 

 

 

 

 

 

By: Stifel, Nicolaus & Company, Incorporated

 

 

 

 

 

 

 

 

 

By:

 

/s/ Keith Lister

 

 

Name:

Keith Lister

 

 

Title:

Managing Director

 

 

[Signature Page to Strongbridge Biopharma plc Acceleration Request]